Form 4: Standard Biotools Executive Reports Stock Transaction
Insider Transaction (Form 4)
Sean Mackay, SVP & Chief Business Officer of Standard Biotools Inc., reported a transaction in 25,729 shares of common stock on August 20, 2026.
Summary
- Tax/exercise-price withholding: disposed of 25,729 Common Stock at $0.67 ($17,290) on August 20, 2026; holds 1,480,823 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Sean Mackay — Officer (SVP & Chief Business Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-20 | Tax/exercise-price withholding | Common Stock | 25,729 | $1 | $17.3K | 1,480,823 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-20 | Tax/exercise-price withholding (25,729 shares) |
Keywords
insider transaction, Form 4, LAB, STANDARD BIOTOOLS INC., neutral, Sean Mackay
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.